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In Brief
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mass spectrometric strategy, to quantify
the levels of more than 500 circulating
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individuals (total of 1,700 plasma
proteins). The resulting global correlation
map of the plasma proteome contained
about 200,000 relationships and revealed
functionally connected protein modules.
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Obesity-related diseases affect half of the global
population, and bariatric surgery is one of the few in-
terventions with long-lasting weight loss and cardio-
metabolic effects. Here, we investigated the effect of
Roux-en-Y gastric bypass surgery on the plasma
proteome, hypothesizing that specific proteins or
protein patterns may serve as key mediators and
markers of the metabolic response. We performed
mass spectrometry (MS)-based proteomics on two
longitudinal studies encompassing 47 morbidly
obese patients, generating quantitative information
on more than 1,700 proteins. A global correlation
matrix incorporating about 200,000 relationships re-
vealed functional connections between proteins
and assigned them to physiological processes. The
main classes of significantly altered proteins were
markers of systemic inflammation and those
involved in lipid metabolism. Our data highlight
robust correlative and anti-correlative behaviors of
circulating proteins to each other and to clinical pa-
rameters. A group of inflammation-related proteins
showed distinct inverse relationships to proteins
consistently associated with insulin sensitivity.
INTRODUCTION
Over 600million people are obese (BMI > 30 kg/m2) and a further
1.3 billion overweight (W.H.O., 2016). The proportion of the latter
subgroup has doubled since 1980, representing an unprece-
dented number of people predisposed to or already affected
by a broad spectrum of co-morbidities (GBD 2015 Obesity
Collaborators et al., 2017). These include type 2 diabetesCell Systems 7, 601–612, Decem
This is an open access article under the CC BY-N(T2D), cardiovascular disease, endocrine disturbances, neuro-
degenerative diseases, and several types of cancers.
In response to this global and dramatically increasing burden,
the scientific community has devoted substantial efforts to
obesity and its clinical consequences, aiming to gain a deeper
understanding of the underlying disease mechanisms while
developing new treatment possibilities. From a vast array of
dietary, behavioral, and pharmacological alternatives, bariatric
surgery has emerged as the most effective intervention for treat-
ing obesity and T2D. There are different bariatric procedures,
with Roux-en-Y gastric bypass (RYGB) among the most estab-
lished ones, where the creation of a small gastric pouch and
bypass of the stomach and upper small intestine, causes accel-
erated entry of nutrients into the small intestine (Griffen et al.,
1977; Mason and Ito, 1967; Mason et al., 1975; Wittgrove
et al., 1994). Besides major weight loss (on average 40 kg), the
physiological responses to RYGB include broad improvements
in cardiovascular status and other measures of metabolic health
(Aab et al., 2016; Adams et al., 2017; Cardoso et al., 2017; Mads-
bad and Holst, 2014; Sjo¨stro¨m et al., 2007). Interestingly, RYGB
strongly increases insulin sensitivity for many individuals
suffering from T2D. Hepatic insulin sensitivity tends to improve
markedly within a week after surgery, even before substantial
weight loss, followed by increased sensitivity in peripheral tis-
sues in weeks (Bojsen-Møller et al., 2014). While gastrointestinal
peptides, bile acids, and even the microbiome have been impli-
cated in the rapid and drastic physiological changes after RYGB,
the molecular mechanisms are poorly understood (Cummings
and Rubino, 2018; Miras and le Roux, 2013).
Metabolic processes are regulated by proteins, and the tech-
nology of choice to study changes in the proteome in an unbi-
ased manner is mass spectrometry (MS)-based proteomics
(Aebersold and Mann, 2016). Proteins circulating in the blood
can be both mediators of organ cross talk and markers of
whole-body states. However, a system-wide approach has
only recently become possible due to technological improve-
ments of the proteomic pipeline (Geyer et al., 2017). We recentlyber 26, 2018 ª 2018 The Author(s). Published by Elsevier Inc. 601
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
developed ‘‘plasma proteome profiling’’ as a robust and auto-
mated platform for the reproducible analysis of hundreds of
clinical samples. The quantified proteome included the main
functional plasma proteins such as the complement system,
apolipoproteins, and other transporters and allowed assessment
of sample quality (Geyer et al., 2016a). In a subsequent study,
we investigated the longitudinal effects of caloric restriction-
induced weight loss on the plasma proteome of 52 individuals
over more than a year. Analysis of more than 1,000 individual
plasma proteomes revealed that protein levels in general were
much more stable within individuals over time than between
them. We extracted panels indicative of systemic inflammatory
status, allowing stratification of the cohorts. The data also high-
lighted specific proteins correlated to relevant clinical parame-
ters such as BMI, high-density lipoprotein (HDL), low-density
lipoprotein (LDL) and insulin sensitivity (Geyer et al., 2016b).
Here, we wished to gain further insights into the global meta-
bolic changes causedbyRYGBsurgery as reflected in the plasma
proteome. To obtain robust and generalizable results,we selected
two studies with similar design to investigate improvements in
hepatic insulin sensitivity and beta cell function (Bojsen-Møller
et al., 2014; Martinussen et al., 2015). We applied an improved
version of our plasma proteome profiling pipeline, which doubled
our coverage of the plasma proteome. Furthermore, for a more
comprehensive understanding of the dynamics of the plasmapro-
teome, we implemented global correlation maps. These consist
of hundreds of thousands of protein-protein connections and
protein-clinical parameter associations, highlighting co-regulated
proteins and revealing underlying physiological mechanisms.
RESULTS
In-Depth Dataset of the Human Plasma Proteome
in RYGB
Study 1 consisted of 20 and study 2 of 27morbidly obese individ-
uals, with BMI 40 ± 4 kg/m2 (Bojsen-Møller et al., 2014) and 42 ±
4 kg/m2 (Martinussen et al., 2015), respectively (Figure 1A).
Blood was drawn at four time points, once directly before and
three times after surgery (0, 1, 12, and 52 weeks). From 19 indi-
viduals, we also obtained blood samples at 2 or 4 years post
operation (>104 weeks).
Weight declined steadily in the cohorts, stabilizing at an average
loss of 28%of total bodymass 1 year after surgery (Figure 1A). In-
sulin resistance of the liver as estimated by homeostatic model
assessment of insulin resistance (HOMA-IR), decreased from
3.3 ± 0.7 to a near normal value of 2.0 ± 0.9 after 12 weeks.
In this study, we further improved the plasma proteome
profiling pipeline by first generating deep plasma libraries by
consecutive depletions of pooled plasma from the top6 and the
top14 highest abundant proteins. Following depletion, we used
the recently developed high-pH reversed-phase ‘‘spider fraction-
ator’’ (Kulak et al., 2017) to generate a deep library of 1,928
plasma proteins and 14,588 peptides (excluding contaminants)
(Figure 1B). Cohort samples were automatically prepared without
any depletion as described previously (Geyer et al., 2016a) (Fig-
ure 1C). The second improvement of our workflow was a new
acquisition method termed BoxCar, which results in about a
10-fold increase in dynamic range of peptide signals via an equal-
ized filling pattern of the ion trap. This results in substantial602 Cell Systems 7, 601–612, December 26, 2018coverage of undepleted plasma samples even without fraction-
ation (Meier et al., 2018), which is visually reflected in isotope pat-
terns detected in the m/z retention time plane for the full scans
(Figure S1).
We generated a large plasma proteome dataset, comprising a
total of 175 human plasma proteomes. In triplicate analysis of the
samples, an average of 1,025 proteins was identified per study
participant, more than twice the number in our previous plasma
proteome study (Geyer et al., 2016b) (Figure 1D; Table S1). In
total, we quantified 1,700 plasma proteins with at least two pep-
tides in the study samples (Figures 1D and 1E). We also evalu-
ated the cohorts based on our previously defined sets of quality
markers. None of the samples suffered from extensive erythro-
cyte lysis or partial coagulation, but we observed a slight trend
toward higher erythrocyte lysis in study 2 (Figure S2).
As this is the largest proteome dataset generated by unbiased
MS-based proteomics on non-depleted plasma, we provide the
data in an easily accessible and minable format for use by the
community (Table S1). Ranking the proteins according to their
abundance and annotating them according to their function
using the Gene Ontology biological process (GOBP) terms and
performing an one-dimensional annotation enrichment analysis
resulted in 117 statistically significant terms (Figure 1F). At this
depth of coverage, processes connected to lipid transport,
coagulation, and inflammation are very well reflected in the
higher abundance ranges, whereas intracellular processes —
presumably as a result of tissue leakage — are enriched in the
low abundance ranges (Table S2).
Plasma Proteome Rearranges after RYGB
Our primary aim was to investigate plasma proteome dynamics
afterRYGBand to relate these to thepathophysiological changes
stemming from the procedure. Over the entire time course, the
levels of 114 proteins changed significantly (Table S3). We ex-
pected the surgery intervention itself to have a strong effect on
the plasma proteome. Indeed, most of the significantly altered
proteins — 88 in total — changed 1 week after surgery; 39 pro-
teins after 12 and 52 weeks; and 33 proteins after more than 2
years. The two longitudinal studies differed onlyminimally in their
design, allowing us to initially use study 1 as the ‘‘discovery
cohort’’ and study 2 as the ‘‘validation cohort’’ according to the
‘‘rectangular strategy’’ for plasma proteome profiling (Geyer at
al., 2017). For the first two time points, where the number of sam-
ples was most comparable, 90% of the significantly changed
proteins in study 1 were also significant in study 2 (Table S3).
Due to the high overlap of proteins regulated in the two indepen-
dent RYGB studies and the fact that we did not detect any signif-
icant differences between them, we henceforth integrated the
data from both of them.
To investigate plasma proteome dynamics after RYGB, we
calculated the median, Z-scored intensities of all significantly
altered proteins at each time point. A hierarchical clustering anal-
ysis stratified proteins into four main groups based on their
response to RYGB (Figures 2A and 2B). Nearly half of these pro-
teins showed a long-term decrease (group 1, 10 proteins; group
2, 40 proteins). The main difference between the two patterns
was that group 2 increased at the first post-operative time point
before dropping below baseline levels for the entire period of up
to 4 years. The 39 proteins in group 3 showed a long-term
Figure 1. Study Design and Analytical Performance
(A) The two studies involved 47 patients who have undergone Roux-en-Y gastric bypass. The boxplots for the BMI distribution indicate a 10–90 percentile, and the
median is highlighted with a black bar.
(B) Highly abundant proteins were only depleted for the library generation in seven pools of plasma. After digestion, peptides were separated at high pH on a
reversed phase material into 24 fractions.
(C) Plasma proteome profiling pipeline applied to 175 plasma proteomes in triplicate. Sample preparation took a total of 4 hr, and 45-min gradients were used,
resulting in a 3D data matrix of quantified proteins as a function of individuals over time.
(D) Number of identified proteins in each of the seven library pools (red dots) and the 175 plasma samples (blue dots).
(E) Total number of proteins identified in the library and in the study cohort.
(F) Quantitative values of 1,700 plasma proteins ranked according to their abundance. Several proteins are exemplified over the abundance range (blue dots).
Functional annotation and 1D enrichment resulted in 117 significantly enriched annotation terms (right graph, gray dots). Eight of these categories are highlighted
as boxplots with a 10–90 percentile.increase, with many of them initially exhibiting a decrease after
surgery. This was also the pattern of group 4, although here
levels only recovered to baseline. The remaining proteins had a
more heterogeneous behavior with increased or decreased
levels between the different time points.
We annotated each of the 114 significantly changed proteins
with GOBP, molecular function (GOMF), and cellular compart-
ment (GOCC) as well as UniProt-KB keyword terms, to reveal
the biological processes that were influenced by RYGB. Fisher’s
exact test on these keyword annotations yielded 322 connec-
tions based on 20 central keywords, drawing a broad picture
of biological functions affected by RYGB (STAR Methods; Table
S4). These range from inflammation, lipid homeostasis, and pro-
tease activity to changes in metal homeostasis.Next, we performed hierarchical clustering on a Boolean table
of the proteins annotated by the 20 keywords, to investigate if
proteins belonging to the same cluster also had a functional asso-
ciation (Figure 2C). Terms related to inflammation were most
strongly enriched (cluster 2). Manual inspection revealed even
more inflammatory proteins, including a frequently clinically
used marker of inflammation, C-reactive protein (CRP), the acute
phase proteins SAA1, SAA4, and lipopolysaccharide binding
protein (LBP), and the complement factors C1S, CFHR3, and
CFHR5. The second most keyword-enriched group belonged to
the lipid homeostasis system (cluster 3), as expected uponweight
loss, and their individual dynamics will be described below.
‘‘Metal binding’’ was also significantly enriched, but spread
over clusters 1, 2, and 3, indicating that RYGB differentlyCell Systems 7, 601–612, December 26, 2018 603
Figure 2. Longitudinal Trajectories and Functional Interpretation of Significantly Influenced Proteins
(A) Proteins clustered into four main groups according to their patterns of adaption after RYGB. Z-scores are plotted over five time points.
(B) Hierarchical clustering of the plasma proteins in the four groups.
(C) A Fisher’s exact test identified 20 main keywords, which were used in a second hierarchical clustering analysis for functional interpretation of the longitudinal
trajectories. The dominant keywords — related to inflammation and the lipid homeostasis system — are highlighted by red and blue rectangles, respectively.
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Figure 3. Global Correlation Map of the
Plasma Proteome
(A) Pairwise correlation of proteins using their in-
tensity levels over the 175 study samples results in a
matrix of correlation coefficients where one protein
is compared to all other proteins and clinical
parameters. The left panel illustrates the calculation
of the Pearson correlation coefficient between two
proteins with high and low correlation, respectively.
The right-handpanel showscross-correlationsof all
quantified proteins and clinical parameters (25%
valid values) after subsequent hierarchical clus-
tering, revealing an extensive map of co-regulated
items (proteins, clinical parameters, peptide glyca-
tion). In the map, items with a strong correlation or
anti-correlation to each other cluster together in red
or blue areas, respectively. The main clusters are
functionally annotated with keywords.
(B) Network analysis of the main clusters in (A)
reveals connections within and between them. The
thickness of the lines corresponds to the Pearson
correlation coefficient (red lines: positive correla-
tions; blue lines: anti-correlations; green cycles:
clinical parameters).affected their functional roles (Table S4). The absorption of iron is
compromised after gastric bypass surgery since the antrum, du-
odenum, and the proximal part of the jejunum, where absorption
takes place is separated from the contact with the ingested
nutrients and results in anemia, due to malabsorption of micro-
nutrients (Worm et al., 2015). Interestingly, levels of transferrin
(TF), the main iron transporter in plasma, increased by 20%
(cluster 3), indicating a sensing mechanism for low iron levels.
In contrast, ceruloplasmin (CP), which oxidizes Fe2+ to Fe3+
for effective transport by TF, was downregulated and present
in cluster 2, which anti-correlates with cluster 3, perhaps
because less iron needs to be oxidized.
We traced the significantly regulated proteins connected
to protease keyword annotations to members of the com-
plement cascade system and different serine protease inhib-
itors (SERPINs). SERPINs are a functionally heterogeneous groupCell Syof proteins, including the inflammation-
associated SERPINA1 and SERPINA3
(cluster 2) and also the adipocyte-secreted
SERPINF1, whose decrease after opera-
tion indicates the lossofbody fat (cluster1).
Encouraged by the fact that plasma
proteomeprofiling revealed specificphys-
iologic changes upon RYGB,we set out to
systematically exploit the observed regu-
lation to construct a global network of
co-regulated plasma proteins and func-
tional modules.
Global Correlation Maps Reveal Co-
regulation of Hundreds of Plasma
Proteins
The levels of plasma proteins have tradi-
tionally been measured and consideredindependently; however, proteins often work together as com-
plexes or groups. Treating RYGB as a generic perturbation, we
next investigated the co-regulation of the plasma proteome at
a systems level to identify protein networks and search for new
biomarker candidates. We constructed a global correlation
map containing pairwise relationships between all proteins and
further included clinical parameters. In our case, there were up
to 175 abundance values for each plasma protein (47 individuals;
5 time points). For instance, the Pearson correlation coefficient
between the apolipoprotein proteins APOA1 and APOC1 was
0.57 over all data points (Figure 3A).
We considered only the 580 proteins that were quantified in at
least 25% of the samples and added 26 clinical parameters. As a
third parameter group, we included the levels of glycated pep-
tides, which are related to blood sugar control and can be deter-
mined by proteomics as previously described (Keilhauer et al.,stems 7, 601–612, December 26, 2018 605
2016). Here, we quantified 203 glycated peptides and combined
them into a single ‘‘peptide glycation’’ factor (STAR Methods).
The protein abundance levels, clinical parameters, and peptide
glycation factor constituted 607 items in total, which we cross-
correlated to generate a matrix of 183,921 correlation coeffi-
cients. Unsupervised hierarchical clustering and color-coding
the correlation coefficients then generated the global correlation
map. We hypothesized that such a map would group the plasma
proteome in such a way that proteins and clinical parameters
associated with the same underlying regulatory mechanism
would cluster in the same area. Thus, the global correlation
map would both capture large-scale organizational features of
the plasma proteome as well as individual associations between
proteins and connect them to measures of disease state repre-
sented by clinical parameters.
A wealth of information can be found in the correlation map
(Figure 3A), with co-regulated areas as large as 76 3 76 items
and as small as binary associations. For functional interpretation,
we employed bioinformatic keyword annotation and subsequent
Fisher’s exact tests. The largest structure belonged to the innate
immune system andwas further dominated by a sub-cluster with
very strong correlations. A cluster consisting of immunoglobulins
was nearly as large as 68 3 68. The global correlation analysis
also identified a cluster dominated by HDL but also containing
adiponectin (the protein and the clinical parameter), which is
positively associated with peripheral insulin sensitivity (Lihn
et al., 2005). Out of more than 20 clusters of similar size, one is
associated with LDL particles, another with proteins partici-
pating in the coagulation cascade such as the von Willebrand
factor (vWF) and fibrinogens, and one contains three steroid-
binding proteins (PZP, SHBG, and SERPINA6).
The strongly correlated sub-cluster of the inflammation sys-
tem includes proteins such as CRP, SAA1, and members of
the complement cascade. Furthermore, it contains diabetes-
associated clinical parameters such as insulin levels, C-peptide
levels, and HOMA-IR, which reflects insulin resistance (Fig-
ure 3A). The fact that these disease markers correlate directly
within the group of inflammation proteins reflects a link between
insulin resistance and systemic inflammation, which is the
subject of extensive metabolic research (Moran et al., 2005;
Ndumele et al., 2006). Notably, there are also anti-correlating
clusters, characterized by off-diagonal areas in the global corre-
lation map (Figure 3A, blue patterns). The main clusters contain
inflammation-associated proteins, apolipoproteins, and insulin-
sensitivity parameters. For instance, there is a negative correla-
tion between CRP and adiponectin of 0.35, highlighting direct
protein-based connections between decreased inflammatory
status and increased insulin sensitivity.
Clearly, the global correlation map contains a treasure trove of
information about the plasma proteome, encoded in its almost
200,000 correlations. Co-regulated proteins identify proteins
associated with diverse physiological processes. Apart from
the most apparent functional associations, there are many clus-
ters with no significant keywords as well as many novel connec-
tions within the clusters.
Interestingly, some clusters contained information about
the sample analysis procedure. These included a tightly co-
regulated group of platelet proteins. Although they accurately
report on sample quality, they do not reflect intrinsic plasma pro-606 Cell Systems 7, 601–612, December 26, 2018teome properties and were therefore removed from downstream
analysis (STAR Methods).
To explore the connections between plasma proteins in a
complementary way, we generated a network in which the
connections are given by their correlation coefficients. For all
proteins and clinical parameters in the 20 clusters with the
highest number of nodes, we only selected proteins with corre-
lation coefficients of at least 0.4 to display their relationship
within and between these clusters (Figure 3B). This highlights
the connections within main physiological processes. In the
inflammation cluster, for instance, there are strong relationships
of the complement system to other inflammatory proteins such
as LBP. The network clearly captures the relationship of inflam-
mation, insulin resistance, and lipid metabolism.
RYGB and the Response to Low-Grade Inflammation
Inflammation-associated proteins were found in the largest
co-regulated cluster, and they also contained the most highly
regulated ones after RYGB (Figures 2 and 4). The connection
of obesity, metabolic diseases, and systemic inflammation has
been investigated extensively on the molecular and cellular level
(Brestoff and Artis, 2015; Osborn and Olefsky, 2012; Quante
et al., 2015). Plasma proteome profiling of a cohort of morbidly
obese individuals undergoing surgical intervention followed by
strong weight loss presents a unique opportunity to investigate
changes in the inflammatory response in a systems-wide and
unbiased manner. In contrast to previous candidate-driven
approaches, our strategy can in principle retrieve association
of any plasma protein with weight-related inflammation. To
define an inflammatory panel in an unbiased manner, we filtered
for relevant keywords (STAR Methods). This resulted in 51 pro-
teins that covered the major pathways, such as complement
activation and acute phase reaction. This inflammatory panel
was quantified with high consistency in the dataset (90% valid
values). We combined the changes of these proteins, normalized
to their starting level, into a single value by taking the median,
which represents a robust and accurate reflection of the global
inflammation status of each individual at each time point. Then,
we aggregated the inflammatory status of all participants over
time. The longitudinal trajectory of this inflammation status had
a maximum at the first post-operative time point with an average
increase of 10% (Figure 4A), presumably as a direct conse-
quence of the surgery (Finnerty et al., 2013). Following this brief
increase, the global inflammation panel decreased gradually,
reaching baseline level 12 weeks after RYGB surgery and the
minimum of 11% at the final time point (>104 weeks). This
dynamic regulationwas quite consistent across almost all partic-
ipants in the study cohort (Figure S3A).
Proteins included in our inflammation panel were selected by
keyword annotation, which could be spurious, including proteins
with negative correlation to inflammation. To assess their suit-
ability as markers, we inspected their dynamics and found that
the large majority went up at the immediate post-operative
time point and stabilized at lower levels at 52 and greater than
104 weeks (Figure 4A). Next, we compared our data to a plasma
proteomic profiling study where weight loss was induced by
caloric restriction (Cambridge diet), in which 43 participants
lost on average 12% of their bodymass during an 8-week period
and maintained their weight for 1 year (Iepsen et al., 2015). From
Figure 4. Connection between Global Inflammation Status and
Body Mass
(A) Changes of the global inflammation status of all study participants. The
global inflammation status is calculated as the median of 51 inflammation
proteins, selected by keyword annotation. Pie charts over each of the post-
operation time points show the number of proteins, which were up- or
downregulated.
(B) Overlap of inflammation proteins in the caloric restriction (CR) and the
RYGB studies. Plus and minus indicate if a protein was decreased in both or in
one of the two studies. The color code shows how many of the proteins were
significantly regulated.
(C) Correlation plot of protein intensities with the BMI in the RYGB study.
Inflammation proteins are highlighted in red or orange if they were significantly
or not significantly correlated to the BMI, respectively. All proteins above the
dashed line show significant correlations.that study, we had already defined a ten protein inflammation
panel (Geyer et al., 2016b), which was completely contained in
the current one. After exclusion of the first post-operative
time point in the RYGB study, we calculated the slope of the
inflammation proteins in both studies across all time points
(Table S5). Between caloric restriction achieved through the
Cambridge diet and by RYGB surgery, there was an overlap in
31 increased inflammation proteins. Thus, the direction of
changes in the full 51 panel in the previous study generally
agreed with the current one (Figure 4B). CRP, a prominent risk
factor for cardiovascular disease, showed the strongest
response, and its levels increased 5-fold at the 1-week time point
and decreased 14-fold afterwards.
For further insights into the connection of the plasma prote-
ome to weight loss, we correlated all 1,700 quantified plasma
proteins directly to BMI. In total, 51 proteins had a significant
correlation, of which 18 were part of our inflammation panel (Fig-
ure S3B; Table S6). CRP, complement factor C3, and S100A8
were the proteins with the strongest correlation (Pearson corre-
lation of 0.63, 0.61, and 0.45, respectively). Together with the
fact that the BMI clustered with inflammation-annotated proteins
in the global correlation map, this underlines the strong connec-
tion between inflammation and obesity.
Core Proteins in Lipid Metabolism Are Significantly
Altered by RYGB
Lipid homeostasis was the second most strongly affected phys-
iological system by RYGB, and it clustered into two distinct
regions of the global correlation map (Figure 2). Many of the
proteins found in this cluster are well-known constituents of
different lipoprotein particles such as APOB or receptors of
these particles such as the LDL receptor (LDLR). To elucidate
their behavior, we filtered the identified plasma proteome for
the Gene Ontology cellular compartment (GOCC) terms ‘‘lipid
transport,’’ ‘‘chylomicron,’’ ‘‘high density lipoprotein (HDL),’’
‘‘low density lipoprotein (LDL),’’ ‘‘intermediate density lipoprotein
(IDL),’’ and ‘‘very low density lipoprotein (vLDL)’’ particle. To this
set, we added non-annotated proteins well known to be associ-
ated with lipid metabolism such as apolipoprotein D (APOD),
apolipoprotein(a) (LPA), Prolow-density lipoprotein receptor-
related protein 1 (LRP1), and phospholipid transfer protein
(PLTP). Excluding the keyword-annotated inflammation proteins
SAA1, SAA2, and SAA4 resulted in 25 proteins that reflect the
lipid homeostasis system in blood. They were consistently quan-
tified across all patients and time points. Furthermore, their
correlation map reveals a large degree of similarity between
the caloric restriction and RYGB studies (Figures 5A and 5B).
For instance, the highly correlated clusters for apolipoproteins
APOC1, APOC2, APOC3, APOC4, and APOE, which are LDL
constituents, are almost superimposable. Likewise, the HDL
related proteins—APOA1, APOA2, APOA4, and PON1— corre-
lated highly.
Inspecting the direction of changes in the expression levels of
proteins, we found that the HDL constituents APOA1, APOA2,
APOA4, and PON1 increased in RYGB but decreased in caloric
restriction, reflecting the HDL laboratory values that were
measured independently in these studies (Figure S4). Further-
more, HDL-associated proteins such as APOC1, APOC2,
APOC4, APOM, PLTP, LPA, and several others that may beCell Systems 7, 601–612, December 26, 2018 607
Figure 5. Response of Lipid Homeostasis Regulating Proteins to RYGB and Caloric Restriction
(A) Correlation maps of lipid homeostasis-associated proteins in the RYGB study.
(B) Correlation maps of lipid homeostasis-associated proteins in the caloric restriction study.
(C) Median of protein intensities showing increased or decreased expression after RYGB and caloric restriction (CR). Significantly changed proteins are marked
with an asterisk.associated were regulated in opposite directions. One of those
— APOC1 — has broad physiological functions including
inhibition of fatty acid uptake from adipocytes and inhibition of
lipoprotein binding to LDL. Interestingly, APOC1 was a member
of both the LDL and HDL correlation clusters. In caloric restric-
tion, its levels decreased by 12%, whereas in RYGB they
increased by 7%. This could be due to a lower need for transport
of fatty acids after caloric restriction but not after RYGB andmay
reflect themechanistic differences of these twoweight loss inter-
ventions. Interestingly, mice overexpressing APOC1 seem pro-
tected for obesity and insulin resistance due to reduced fatty
acid uptake in adipocytes (Jong et al., 2001).
After RYGB, insulin sensitivity of the liver rapidly improves
(Bojsen-Møller et al., 2014). In line with this, we observed in-
creases in APOA4, another surrogate marker of hepatic insulin
sensitivity (VerHague et al., 2013).
Improvement in Insulin Sensitivity after RYGB Is
Reflected in the Plasma Proteome
The immediate positive effect of RYGB on insulin sensitivity has
been widely discussed, but any reflections of this in the plasma
proteome have not been described. In both RYGB cohorts, we
determined hepatic insulin resistance by the HOMA-IR based
on C-peptide, and, in study 1, we further measured ‘‘hepatic
insulin sensitivity’’ by tracer estimation of hepatic glucose pro-
duction, ‘‘peripheral insulin sensitivity’’ by the hyperinsulinemic
euglycemic clamp and ‘‘oral glucose insulin sensitivity’’ from
oral glucose tolerance test, resulting in a system-wide assess-
ment of insulin sensitivity (Figure S5).
Connecting the insulin sensitivity measures to the plasma
proteome profile retrieved 75 significantly correlating proteins
(Figures 6A and 6B; Table S7). Adiponectin, sex hormone-bind-
ing globulin, vitamin K-dependent protein S, cholinesterase, the
complement factors C3, CFB, and C4-binding protein alpha
chain correlated with all four assessments. We calculated a
summed insulin sensitivity correlation, taking the strength and
number of correlations into account and followed this measure608 Cell Systems 7, 601–612, December 26, 2018over time since surgery (Figure 6C; Table S8). This factor
reached its maximum 1 year after the gastric bypass operation.
Interestingly, the summed insulin sensitivity correlation was
almost superimposed in both studies (Figure 6B), validating the
individual correlating proteins.
Reassuringly, adiponectin, a classical marker for insulin
sensitivity, was the protein with the highest score (ADIPOQ;
S:16), and sex hormone-binding globulin (SHBG; S:8) and com-
plement factor C3 (C3; S:8) were likewise in the top group.
Strikingly, another 25 proteins and the ‘‘peptide glycation’’ fac-
tor correlated or anti-correlated highly with insulin sensitivity
(Figure 6A). Other proteins in this heterogeneous group
included pigment epithelium-derived factor (SERPINF1; S:11),
afamin (AFM; S:10), antithrombin-III (SERPINC1; S:9), and apoli-
poprotein A1 (APOA1; S:8). Note that some of these correla-
tions may simply reflect the weight loss, rather than a more
specific effect on insulin sensitivity. For instance, SERPINF1,
a protein secreted by adipocytes, is clearly and highly signifi-
cantly anti-correlated to insulin sensitivity — especially to he-
patic insulin sensitivity (Pearson’s R 0.66; p < 109). Of
note, we had previously found a strong association of SER-
PINF1 and weight loss in the caloric restriction study as well
as a correlation to insulin resistance based on HOMA-IR (Geyer
et al., 2016b). It would be interesting to determine if SERPINF1
has a functional involvement in insulin sensitivity or if it mainly
reflects total fat mass.
Conversely, a group of high-scoring proteins reflecting the
inflammatory state and lipid transport likely represent functional
connections: both systemic inflammation and dysregulated lipid
homeostasis. These included several components of the com-
plement system and a number of apolipoproteins, which also
correlated or anti-correlated with insulin sensitivity measures in
our global correlation map (Figure 3; Table S8). Clearly, our
protein correlation profiles reflect the complex relationships
between insulin sensitivity, lipid homeostasis, and inflammation.
However, the majority of proteins correlated with insulin sensi-
tivity had no reported connection to these two physiological
Figure 6. Correlation to Insulin Sensitivity Assessments
(A) Correlation of the plasma proteome profile to the four insulin sensitivity assessments: hepatic insulin sensitivity, homeostatic model assessment of insulin
resistance based onC-peptide (HOMA-IR), peripheral insulin sensitivity, and oral glucose insulin sensitivity. Pearson correlationswere rank-ordered, and proteins
grouped, scored, and color-coded from 1 to 4.
(B) Example correlations of four proteins to the insulin sensitivity assessments.
(C) Trajectories of the summed insulin sensitivity correlations defined in (A) over time. Blue, RYGB study 1; gray, RYGB study 2.processes. As insulin has a broad effect on different organs, it
is not surprising that proteins of different physiological pro-
cesses correlated to insulin sensitivity, which makes them inter-
esting candidates to study as cause or consequence of insulin
resistance.
DISCUSSION
Bariatric surgery fundamentally alters human metabolism, and
much remains to be learned about the molecular mechanisms
underlying surgical therapies such as RYGB. The majority of
research has focused on anthropometric as well as clinical and
physiological data (Puzziferri et al., 2014), whereas there are
few hypothesis-free approaches (Arora et al., 2015; Luo et al.,
2016). In this work, we aimed to describe global rearrangements
of the plasma proteome in a systems-wide view and discover
protein markers of gastric bypass surgery with possible func-
tional relevance. This was enabled by a recently developed
robust and highly reproducible pipeline for MS-based investiga-
tion of plasma, which we termed plasma proteome profiling
(Geyer et al., 2016a). In the current study, we integrated several
technological advances into the workflow including the spider
fractionator to generate deep peptide libraries and combined it
for the first time with the BoxCar scan method to increase thedynamic range of our measurements (Meier et al., 2018).
Together, this achieved the most extensive quantitative plasma
proteome so far, providing the community with concentration es-
timates of over 1,700 proteins and their bioinformatic keyword
annotations.
We described longitudinal trajectories of 114 significantly
altered proteins in response to RYGB and applied functional
annotation analysis to reveal the underlying physiological mech-
anisms. This identified twomain groups, belonging to the inflam-
mation and the lipid homeostasis systems. We found a strong
overlap of inflammation proteins in RYGB with our previous
study on caloric restriction-induced weight loss (Geyer et al.,
2016b) with the same regulation and tight correlation to BMI.
We conclude that body mass is a major determinant of systemic
low-grade inflammation levels and that weight loss— regardless
of the mode by which it is achieved — is its most important
driver. These dramatic changes are illustrated by regulation of
51 inflammation-associated proteins, the most prominent of
which is CRP that decreased 14-fold during the average weight
reduction of 28%. Note that a few of these proteins were upregu-
lated, for instance, the complement factor C7. Interestingly, our
unbiased analysis revealed that the weight loss-driven decrease
over the subsequent year was as strong as the immediate sur-
gery-induced increase. Such dramatic changes in systematicCell Systems 7, 601–612, December 26, 2018 609
inflammation could affect the risk for cardiovascular events (Da-
nesh et al., 2000).
In contrast to the inflammation system, the lipid homeostasis
system was differently regulated between caloric restriction
and RYGB. While LDL-associated proteins decreased in both
interventions, the HDL-associated cluster was only increased
after RYGB. This is interesting given the link between high
HDL levels and a lower risk of coronary heart disease in asso-
ciative studies but not when increased by pharmacological
intervention (Rader and Hovingh, 2014). At this point, the major-
ity of differently regulated proteins between both types of
weight loss cannot be directly linked to clinically measured
HDL levels alone.
Lipoprotein particles can be sub-classified into several types
that interact or are converted into each other (Kontush et al.,
2013). Proteins are the defining elements of all of them and
could be the basis for more rational classification of the lipid
homeostasis system. In our study, several cardiovascular risk
markers from the lipid homeostasis system such as the LDL-
associated APOB and LPA dropped in both caloric restriction
and RYGB, whereas APOA1, whose levels positively correlate
with decreased cardiovascular risk (Emerging Risk Factors
Collaboration et al., 2012), significantly increased only in
RYGB. A number of such factors emerged from our analyses
(Table S9), and it would be interesting to study them in-depth
for a possible differential involvement in cardiovascular dis-
eases. More generally, it has been widely discussed which
types of cholesterol particles are the most relevant to disease
risk (Krauss, 2010), and our data now suggest that it may be
promising to focus on the different lipoprotein-associated pro-
teins themselves (Hegele, 2009). For the future, we imagine
that plasma proteome profiling of cardiovascular risk studies
may help to unravel the role and biomarker potential of individ-
ual proteins.
The plasma proteome profiles of a well-characterized longi-
tudinal cohort with comprehensive clinical characterization pro-
vided the first opportunity to systematically study the dynamics
of the human plasma proteome. For this purpose, we here
employed global correlation maps, in which we correlated the
quantitative levels of all proteins and clinical parameters to
each other. We sorted the resulting matrix by hierarchical clus-
tering and applied bioinformatic enrichment analysis. This dis-
entangled complex processes in the plasma proteome and
associated proteins to common physiological functions and
clinical risk measures.
Standard clinical parameters for insulin resistance including
insulin levels themselves, C-peptide levels, and HOMA-IR, clus-
tered with proteins of the inflammation system. Hepatic insulin
sensitivity, peripheral insulin sensitivity, and oral glucose insulin
sensitivity all tended to associate with proteins of the lipid
homeostasis system. Network analysis highlighted an anti-
correlation between those two systems (Figure 3B). This is
consistent with the detrimental effect of systemic inflammation
on the risk of metabolic disease and the positive and negative
effects of the levels of different cholesterol lipoprotein particles
(Dali-Youcef et al., 2013; Glass and Olefsky, 2012). Thus, we
here recapitulated the relationships between insulin sensitivity,
the lipid homeostasis system, and systemic inflammation
purely from an unbiased assessment of the plasma proteome610 Cell Systems 7, 601–612, December 26, 2018in a human intervention study for diabetes. Interestingly, our
analysis revealed that known single protein markers of insulin
sensitivity, such as adiponectin (Li et al., 2009), were indeed
the highest scoring ones, and that there are many others that
have not yet been connected to insulin sensitivity (Figure 6;
Table S8).
In conclusion, plasmaproteome profiling is a powerful technol-
ogy for studying the effects of physiological interventions such as
RYGB in humans, which may provide new molecular markers
and targets for the treatment of metabolic syndrome and dia-
betes. The approach can assess changes in circulating proteins
resulting from any metabolic perturbation. Our bioinformatic
analysis integrates these data with existing knowledge, thereby
providing a functional and clinical context for interpretation.
Further streamlining of the analytical methods developed here
will make it possible to measure many clinical studies, building
up a comprehensive ‘‘knowledge base’’ of the human plasma
proteome in health and disease states (Geyer et al., 2017).
STAR+METHODS
Detailed methods are provided in the online version of this paper
and include the following:
d KEY RESOURCES TABLE
d CONTACT FOR REAGENT AND RESOURCE SHARING
d EXPERIMENTAL MODEL AND SUBJECT DETAILS
d METHOD DETAILSB High Abundant Protein Depletion for Building a Match-
ing Library
B Sample Preparation for Study Samples
B High Pressure Liquid Chromatography and Mass
Spectrometry
B Data Analysis
d QUANTIFICATION AND STATISTICAL ANALYSIS
B Global Correlation Analysis
B Inflammation System
B Lipid Homeostasis System
B Scoring System for Insulin Sensitivity
B Insulin Sensitivity Score
d DATA AND SOFTWARE AVAILABILITY
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and nine tables and can be
found with this article online at https://doi.org/10.1016/j.cels.2018.10.012.
ACKNOWLEDGMENTS
We thank all members of the Proteomics and Signal Transduction group (Max-
Planck Institute) and the Clinical Proteomics group (NNF Center for Protein
Research) and in particular, Atul Deshmuk, for their help and discussions. In
addition, we thank Igor Paron, Christian Deiml, Korbinian Mayr, Gaby Sowa,
and Katharina Zettl for technical assistance; and J€urgen Cox for bioinformatic
tools.
The work carried out in this project was partially supported by the Max
Planck Society for the Advancement of Science, the European Union0s
Horizon 2020 research and innovation program (grant agreement no.
686547; MSmed project), the European Commission 7th Research Frame-
work Program (GA ERC-2012-SyG_318987; ToPAG project), and by
the Novo Nordisk Foundation for the Clinical Proteomics group (grant
NNF15CC0001).
AUTHOR CONTRIBUTIONS
N.J.W.A. and P.E.G. designed, performed, and interpreted the MS-based pro-
teomic analysis of patient plasma and wrote the paper and generated the fig-
ures. S.D., P.V.T., F.M., L.N., A.S., and E.C.K. interpreted proteomic data and
revised the manuscript. K.N.B.-M., N.B.J., C.M., S.M., J.J.H., and S.S.T. pro-
vided patient material and clinical data and revised the manuscript. M.M. de-
signed and interpreted the MS-based proteomic analysis of patient plasma,
supervised and guided the project, and wrote the paper.
DECLARATION OF INTERESTS
The authors declare no competing interests.
Received: April 20, 2018
Revised: September 10, 2018
Accepted: October 25, 2018
Published: December 5, 2018
REFERENCES
Aab, A., Abreu, P., Aglietta, M., Ahn, E.J., Al Samarai, I., Albuquerque, I.F.,
Allekotte, I., Allison, P., Almela, A., Alvarez Castillo, J., et al. (2016).
Measurement of the radiation energy in the radio signal of extensive air
showers as a universal estimator of cosmic-ray energy. Phys. Rev. Lett. 116,
241101.
Adams, T.D., Davidson, L.E., Litwin, S.E., Kim, J., Kolotkin, R.L., Nanjee, M.N.,
Gutierrez, J.M., Frogley, S.J., Ibele, A.R., Brinton, E.A., et al. (2017). Weight
and metabolic outcomes 12 years after gastric bypass. N. Engl. J. Med. 377,
1143–1155.
Aebersold, R., and Mann, M. (2016). Mass-spectrometric exploration of prote-
ome structure and function. Nature 537, 347–355.
Arora, T., Velagapudi, V., Pournaras, D.J., Welbourn, R., le Roux, C.W., Oresic,
M., and B€ackhed, F. (2015). Roux-en-Y gastric bypass surgery induces early
plasma metabolomic and lipidomic alterations in humans associated with dia-
betes remission. PLoS One 10, e0126401.
Bojsen-Møller, K.N., Dirksen, C., Jørgensen, N.B., Jacobsen, S.H., Serup,
A.K., Albers, P.H., Hansen, D.L., Worm, D., Naver, L., Kristiansen, V.B., et al.
(2014). Early enhancements of hepatic and later of peripheral insulin sensitivity
combined with increased postprandial insulin secretion contribute to
improved glycemic control after Roux-en-Y gastric bypass. Diabetes 63,
1725–1737.
Bojsen-Møller, K.N., Dirksen, C., Svane, M.S., Jørgensen, N.B., Holst, J.J.,
Richter, E.A., and Madsbad, S. (2017). Variable reliability of surrogate mea-
sures of insulin sensitivity after Roux-en-Y gastric bypass. Am. J. Physiol.
Regul. Integr. Comp. Physiol. 312, R797–R805.
Brestoff, J.R., and Artis, D. (2015). Immune regulation of metabolic homeosta-
sis in health and disease. Cell 161, 146–160.
Cardoso, L., Rodrigues, D., Gomes, L., and Carrilho, F. (2017). Short- and
long-termmortality after bariatric surgery: a systematic review and meta-anal-
ysis. Diabetes Obes. Metab. 19, 1223–1232.
Cox, J., Hein, M.Y., Luber, C.A., Paron, I., Nagaraj, N., and Mann, M. (2014).
Accurate proteome-wide label-free quantification by delayed normalization
and maximal peptide ratio extraction, termed MaxLFQ. Mol. Cell.
Proteomics 13, 2513–2526.
Cox, J., and Mann, M. (2008). MaxQuant enables high peptide identification
rates, individualized p.p.b.-range mass accuracies and proteome-wide pro-
tein quantification. Nat. Biotechnol. 26, 1367–1372.
Cox, J., Neuhauser, N., Michalski, A., Scheltema, R.A., Olsen, J.V., and Mann,
M. (2011). Andromeda: a peptide search engine integrated into the MaxQuant
environment. J. Proteome Res. 10, 1794–1805.
Cummings, D.E., and Rubino, F. (2018). Metabolic surgery for the treatment of
type 2 diabetes in obese individuals. Diabetologia 61, 257–264.
Dali-Youcef, N., Mecili, M., Ricci, R., and Andre`s, E. (2013). Metabolic inflam-
mation: connecting obesity and insulin resistance. Ann. Med. 45, 242–253.Danesh, J., Whincup, P., Walker, M., Lennon, L., Thomson, A., Appleby, P.,
Gallimore, J.R., and Pepys, M.B. (2000). Low grade inflammation and coronary
heart disease: prospective study and updated meta-analyses. BMJ 321,
199–204.
Emerging Risk Factors Collaboration, Di Angelantonio, E., Gao, P., Pennells,
L., Kaptoge, S., Caslake, M., Thompson, A., Butterworth, A.S., Sarwar, N.,
Wormser, D., et al. (2012). Lipid-related markers and cardiovascular disease
prediction. JAMA 307, 2499–2506.
Finnerty, C.C., Mabvuure, N.T., Ali, A., Kozar, R.A., and Herndon, D.N. (2013).
The surgically induced stress response. JPEN J. Parenter. Enteral Nutr. 37,
21S–29S.
GBD 2015 Obesity Collaborators, Afshin, A., Forouzanfar, M.H., Reitsma,
M.B., Sur, P., Estep, K., Lee, A., Marczak, L., Mokdad, A.H., Moradi-Lakeh,
M., et al. (2017). Health effects of overweight and obesity in 195 countries
over 25 years. N. Engl. J. Med. 377, 13–27.
Geyer, P.E., Holdt, L.M., Teupser, D., and Mann, M. (2017). Revisiting
biomarker discovery by plasma proteomics. Mol. Syst. Biol. 13, 942.
Geyer, P.E., Kulak, N.A., Pichler, G., Holdt, L.M., Teupser, D., and Mann, M.
(2016a). Plasma proteome profiling to assess human health and disease.
Cell Syst. 2, 185–195.
Geyer, P.E., Wewer Albrechtsen, N.J., Tyanova, S., Grassl, N., Iepsen, E.W.,
Lundgren, J., Madsbad, S., Holst, J.J., Torekov, S.S., and Mann, M. (2016b).
Proteomics reveals the effects of sustained weight loss on the human plasma
proteome. Mol. Syst. Biol. 12, 901.
Glass, C.K., and Olefsky, J.M. (2012). Inflammation and lipid signaling in the
etiology of insulin resistance. Cell Metab. 15, 635–645.
Griffen, W.O., Jr., Young, V.L., and Stevenson, C.C. (1977). A prospective
comparison of gastric and jejunoileal bypass procedures for morbid obesity.
Ann. Surg. 186, 500–509.
Hegele, R.A. (2009). Plasma lipoproteins: genetic influences and clinical impli-
cations. Nat. Rev. Genet. 10, 109–121.
Iepsen, E.W., Lundgren, J., Dirksen, C., Jensen, J.E., Pedersen, O., Hansen,
T., Madsbad, S., Holst, J.J., and Torekov, S.S. (2015). Treatment with a
GLP-1 receptor agonist diminishes the decrease in free plasma leptin during
maintenance of weight loss. Int. J. Obes. (Lond.) 39, 834–841.
Jong, M.C., Voshol, P.J., Muurling, M., Dahlmans, V.E., Romijn, J.A., Pijl, H.,
and Havekes, L.M. (2001). Protection from obesity and insulin resistance in
mice overexpressing human apolipoprotein C1. Diabetes 50, 2779–2785.
Keilhauer, E.C., Geyer, P.E., and Mann, M. (2016). HCD fragmentation of
glycated peptides. J. Proteome Res. 15, 2881–2890.
Kontush, A., Lhomme, M., and Chapman, M.J. (2013). Unraveling the com-
plexities of the HDL lipidome. J. Lipid Res. 54, 2950–2963.
Krauss, R.M. (2010). Lipoprotein subfractions and cardiovascular disease risk.
Curr. Opin. Lipidol. 21, 305–311.
Kulak, N.A., Geyer, P.E., and Mann, M. (2017). Loss-less nano-fractionator for
high sensitivity, high coverage proteomics. Mol. Cell. Proteomics 16, 694–705.
Li, S., Shin, H.J., Ding, E.L., and van Dam, R.M. (2009). Adiponectin levels and
risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 302,
179–188.
Lihn, A.S., Pedersen, S.B., and Richelsen, B. (2005). Adiponectin: action, regu-
lation and association to insulin sensitivity. Obes. Rev. 6, 13–21.
Luo, P., Yu, H., Zhao, X., Bao, Y., Hong, C.S., Zhang, P., Tu, Y., Yin, P., Gao, P.,
Wei, L., et al. (2016). Metabolomics study of Roux-en-Y gastric bypass surgery
(RYGB) to treat type 2 diabetes patients based on ultraperformance liquid
chromatography-mass spectrometry. J. Proteome Res. 15, 1288–1299.
Madsbad, S., and Holst, J.J. (2014). GLP-1 as a mediator in the remission of
type 2 diabetes after gastric bypass and sleeve gastrectomy surgery.
Diabetes 63, 3172–3174.
Martinussen, C., Bojsen-Møller, K.N., Dirksen, C., Jacobsen, S.H., Jørgensen,
N.B., Kristiansen, V.B., Holst, J.J., and Madsbad, S. (2015). Immediate
enhancement of first-phase insulin secretion and unchanged glucose effec-
tiveness in patients with type 2 diabetes after Roux-en-Y gastric bypass.
Am. J. Physiol. Endocrinol. Metab. 308, E535–E544.Cell Systems 7, 601–612, December 26, 2018 611
Mason, E.E., and Ito, C. (1967). Gastric bypass in obesity. Surg. Clin. North Am.
47, 1345–1351.
Mason, E.E., Printen, K.J., Hartford, C.E., and Boyd, W.C. (1975). Optimizing
results of gastric bypass. Ann. Surg. 182, 405–414.
Meier, F., Geyer, P.E., VirreiraWinter, S., Cox, J., andMann, M. (2018). BoxCar
acquisition method enables single-shot proteomics at a depth of 10,000
proteins in 100 minutes. Nat. Methods 15, 440–448.
Miras, A.D., and le Roux, C.W. (2013). Mechanisms underlying weight loss af-
ter bariatric surgery. Nat. Rev. Gastroenterol. Hepatol. 10, 575–584.
Moran, A., Steffen, L.M., Jacobs, D.R., Jr., Steinberger, J., Pankow, J.S.,
Hong, C.P., Tracy, R.P., and Sinaiko, A.R. (2005). Relation of C-reactive pro-
tein to insulin resistance and cardiovascular risk factors in youth. Diabetes
Care 28, 1763–1768.
Nagaraj, N., Kulak, N.A., Cox, J., Neuhauser, N., Mayr, K., Hoerning, O., Vorm,
O., and Mann, M. (2012). System-wide perturbation analysis with nearly com-
plete coverage of the yeast proteome by single-shot ultra HPLC runs on a
bench top Orbitrap. Mol. Cell. Proteomics 11, M111.013722.
Ndumele, C.E., Pradhan, A.D., and Ridker, P.M. (2006). Interrelationships
between inflammation, C-reactive protein, and insulin resistance.
J. Cardiometab. Syndr. 1, 190–196.
Osborn, O., and Olefsky, J.M. (2012). The cellular and signaling networks link-
ing the immune system and metabolism in disease. Nat. Med. 18, 363–374.
Puzziferri, N., Roshek, T.B., 3rd, Mayo, H.G., Gallagher, R., Belle, S.H., and
Livingston, E.H. (2014). Long-term follow-up after bariatric surgery: a system-
atic review. JAMA 312, 934–942.612 Cell Systems 7, 601–612, December 26, 2018Quante, M., Dietrich, A., ElKhal, A., and Tullius, S.G. (2015). Obesity-related
immune responses and their impact on surgical outcomes. Int. J. Obes.
(Lond.) 39, 877–883.
Rader, D.J., and Hovingh, G.K. (2014). HDL and cardiovascular disease.
Lancet 384, 618–625.
Sjo¨stro¨m, L., Narbro, K., Sjo¨stro¨m, C.D., Karason, K., Larsson, B., Wedel, H.,
Lystig, T., Sullivan, M., Bouchard, C., Carlsson, B., et al. (2007). Effects of
bariatric surgery on mortality in Swedish obese subjects. N. Engl. J. Med.
357, 741–752.
Tyanova, S., Temu, T., Sinitcyn, P., Carlson, A., Hein, M.Y., Geiger, T., Mann,
M., and Cox, J. (2016). The Perseus computational platform for comprehen-
sive analysis of (prote)omics data. Nat. Methods 13, 731–740.
VerHague, M.A., Cheng, D., Weinberg, R.B., and Shelness, G.S. (2013).
Apolipoprotein A-IV expression in mouse liver enhances triglyceride secretion
and reduces hepatic lipid content by promoting very low density lipoprotein
particle expansion. Arterioscler. Thromb. Vasc. Biol. 33, 2501–2508.
W.H.O. (2016). Global Health Observatory (GHO) data. Overweight and
obesity. http://www.who.int/gho/ncd/risk_factors/overweight/en/.
Wittgrove, A.C., Clark, G.W., and Tremblay, L.J. (1994). Laparoscopic gastric
bypass, Roux-en-Y: preliminary report of five cases. Obes. Surg. 4, 353–357.
Worm, D., Madsbad, S., Kristiansen, V.B., Naver, L., and Hansen, D.L. (2015).
Changes in hematology and calciummetabolism after gastric bypass surgery–
a 2-year follow-up study. Obes. Surg. 25, 1647–1652.
STAR+METHODSKEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
Biological Samples
RYGB study 1 Bojsen-Møller et al. (2014) Clinical trial NCT01202526
RYGB study 2 Martinussen et al. (2015) Clinical trial NCT01993511
Chemicals, Peptides, and Recombinant Proteins
Multiple Affinity Removal Spin Cartridge Human 6 Agilent Technologies Cat#5188-5230
High Select Top14 Abundant Protein Depletion Midi Spin Column Thermo Fisher Scientific Cat#A36371
’iST’ Kit for proteomic sample preparation PreOmics GmbH P.O. 00001
Deposited Data
Proteomics data PRIDE ProteomeXchange PXD009348
Software and Algorithms
MaxQuant Cox and Mann (2008) Version 1.5.9.4
Perseus Tyanova et al. (2016) Version 1.5.5.5CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Matthias
Mann (mmann@biochem.mpg.de).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
RYGB study 1: Ten obese patients with type 2 diabetes (age 43.6 ± 3.4 years, male/female 4/6, BMI 38.9 ± 1.6 kg/m2, HbA1c
7.0 ± 0.3%, diabetes duration 3.3 ± 1.0 years) and ten obese patients with normal glucose tolerance (age 40.1 ± 2.8 years, male/
female 3/7, BMI 40.2 ± 0.8 kg/m2, HbA1c 5.4 ± 0.1%) scheduled for laparoscopic Roux-en-Y gastric bypass (RYGB) were investi-
gated before (n=20), 1 week (n=16), 3 months (n=20) and 1 year (n=18) postoperatively (Clinical trial NCT01202526), as described
previously (Bojsen-Møller et al., 2014). At 4 years post-RYGB, an extension study (NCT03046147) was initiated and 16 patients of
the initial cohort accepted to be included. Written informed consent was obtained from all participants and the study was approved
by the Municipal Ethical Committee of Copenhagen in accordance with the Helsinki declaration and by the Danish Data Protection
Agency. Triple sampling at fasting was performed at all study visits, while hyperinsulinemic-euglycemic clamps (HEC) including basal
glucose tracer infusions were performed at all except the 4 year’s visit as previously described in detail. Oral glucose tolerance tests
(OGTTs) were done on separate study days before, 3 months, 1 year and 4 years after RYGB. Antidiabetic agents were discontinued
R3 days before each study day, and participants were instructed to refrain from strenuous physical activity and alcohol for 3 days
and to fast overnight (10-12 h) prior to all experiments. Calculations: HOMA2-IR was calculated from all study visits based on a triple
sampling of fasting glucose and C-peptide concentrations using the HOMA2. Hepatic insulin sensitivity and peripheral insulin sensi-
tivity were estimated fromHECexperimental days as the tracer determined basal rate of appearance (Ra) of glucose (inmgperminute)
with correction for C-peptide concentrations and the tracer determined rate of disappearance (Rd) of glucose during the HEC ex-
pressed as mg per min per kg fat free mass (ffm), respectively. The Oral Glucose Insulin Sensitivity index was estimated from all
OGTTs and has recently been validated against the HEC in this particular cohort (Bojsen-Møller et al., 2017).
RYGB study 2: Participants: Ten obese patients with type 2 diabetes (age 46.1 ± 2.8 years, male/female 4/6, BMI 41.2 ± 1.3 kg/m2,
HbA1c 45.1 ± 2.2mmol/mol, diabetes duration 3.6 ± 1.3 years), seven obese patients with impaired glucose tolerance (age 41.8 ± 3.7
years, male/female 2/5, BMI 40.3 ± 1.6 kg/m2, HbA1c 40.0 ± 1.0 mmol/mol) and ten obese patients with normal glucose tolerance
(age 41.6 ± 3.0 years, male/female 4/6, BMI 43.8 ± 1.5 kg/m2, HbA1c 35.0 ± 1.3 mmol/mol) were examined before (n=27) and 1 week
(n=25) and 3months (n=25) after RYGB (NCT01993511) as previously described (Martinussen et al., 2015). A few of the patients were
also investigated after 1 year (n=6) and 2 years (n=3) postoperatively. Written informed consent was obtained from all participants
and the study was approved by the Municipal Ethical Committee of Copenhagen in accordance with the Helsinki declaration and
by the Danish Data Protection Agency. Triple sampling at fasting was performed at all study visits. Oral glucose tolerance testing
was done on separate study days before (n=23) and 3 months (n=23) and 1 year (n=5) after RYGB. Antidiabetic medication was
discontinued >3 days (>10 days for Liraglutide) prior to surgery and patients were instructed to fast overnight (10-12 hours) prior
to testing. Calculations: HOMA2-IR and oral glucose insulin sensitivity was obtained as described for study 1.Cell Systems 7, 601–612.e1–e3, December 26, 2018 e1
METHOD DETAILS
High Abundant Protein Depletion for Building a Matching Library
To construct a library of peptide identifications, we used two commercial depletion kits that together remove the top14 highest abun-
dant proteins in plasma (Geyer et al., 2016a). Following depletion, we separated our samples into 24 fractions, using our recently
developed high-pH reversed-phase ‘Spider fractionator’ (Figure 1B) (Kulak et al., 2017).
Sample Preparation for Study Samples
Plasma samples for the quantitative analysis of the two bariatric surgery cohorts were prepared for all samples according to the
previously published Plasma Proteome Profiling pipeline (Geyer et al., 2016a). In brief, this involved optimized conditions for
denaturation, alkylation, digestion and peptide purification, and liquid chromatography and MS settings. Sample preparation was
carried out in an automated liquid handling platform (Agilent Bravo) in a 96 well format. For sample preparation, we used the ’iST’
Kit for proteomic sample preparation (P.O. 00001, PreOmics GmbH). Depletion was only used for the library and not for the study
samples.
High Pressure Liquid Chromatography and Mass Spectrometry
Samples were measured using LC-MS instrumentation consisting of an EASY-nLC 1200 system (Thermo Fisher Scientific), which
was combined with a Q Exactive HF Orbitrap (Thermo Fisher Scientific) and a nano-electrospray ion source (Thermo Fisher Scien-
tific). Purified peptides were separated on 40 cm HPLC-columns (ID: 75 mm; in-house packed into the tip with ReproSil-Pur C18-AQ
1.9 mm resin (Dr. Maisch GmbH)). For each LC-MS/MS analysis, around 1 mg peptides were used for the 45 min gradients and for the
fractions of the deep plasma data set. Peptides were loaded in buffer A (0.1% formic acid, 5% DMSO (v/v)) and eluted with a linear
35 min gradient of 3-30% of buffer B (0.1% formic acid, 5% DMSO, 80% (v/v) acetonitrile), followed by a 7 min increase to 75% of
buffer B and a 1 min increase to 98% of buffer B, and a 2 min wash of 98% buffer B at a flow rate of 450 nl/min. Column temperature
was kept at 60C by a Peltier element containing in-house-developed oven. MS data were acquired with a Top15 data-dependent
MS/MS scan method (topN method) for the library and the BoxCar scan method (Meier et al., 2018) for the study samples. Target
values for the full scan MS spectra was 3 x 106 charges in the 300-1,650 m/z range with a maximum injection time of 55 ms and
a resolution of 120,000 at m/z 200. Fragmentation of precursor ions was performed by higher-energy C-trap dissociation (HCD)
with a normalized collision energy of 27 eV. MS/MS scans were performed at a resolution of 15,000 at m/z 200 with an ion target
value of 5 x 104 and a maximum injection time of 25 ms.
Data Analysis
MS raw files were analyzed using the MaxQuant software (Cox and Mann, 2008) and peptide lists were searched against the human
Uniprot FASTA database with the Andromeda search engine (Cox et al., 2011). A contaminants databasewas employed and cysteine
carbamidomethylation was set as a fixed modification and N-terminal acetylation and methionine oxidations as variable modifica-
tions. False discovery rate (FDR) was 0.01 for both the protein and peptide level with a minimum length of 7 amino acids for peptides
and this FDR was determined by searching a reverse sequence database. Enzyme specificity was set as C-terminal to arginine and
lysine as expected using trypsin and LysC as proteases, and amaximum of twomissed cleavageswere allowed. Peptides were iden-
tified with an initial precursor mass deviation of up to 7 ppm and a fragment mass deviation of 20 ppm. ‘Match between run algorithm’
in MaxQuant (Nagaraj et al., 2012) was performed after constructing a matching library consisting of depleted plasma samples. All
proteins and peptides matching to the reversed database were filtered out. For label-free protein quantitation (LFQ) we required a
minimum ratio count of 2 (Cox et al., 2014). Glycated peptide were identified as previously reported (Keilhauer et al., 2016).
QUANTIFICATION AND STATISTICAL ANALYSIS
All bioinformatic analyses were done with the Perseus software of the MaxQuant computational platform (Cox and Mann, 2008;
Tyanova et al., 2016). For statistical analysis of significantly changed proteins before and after RYGB, we used a one-sample t-
test with a false discovery rate of <0.05 after Benjamini-Hochberg correction. Correlation to clinical parameters like BMI and insulin
resistance data to MS-based proteomic data were also done within the Perseus environment.
Global Correlation Analysis
Proteins were only considered for the analysis, if they were present in at least 25% of all samples, which is equal to 44 out of the 175
measured samples. After removal of potential contaminants like platelet proteins, this left 580 proteins. Peptide glycation: Quantified
glycation sites were also filtered for at least 25% valid values and Z-scored over all individuals and time points. The median of this
normalized index over 203 glycation sites is reported as the ‘peptide glycation’ factor.
Inflammation System
We filtered for proteins of the inflammation system by including keywords enriched in the analysis of Figure 2 (complement pathway,
immunity, innate immunity, membrane attack complex, cytolysis, complement alternate pathway, inflammatory response, antimicro-
bial) and further included the term ‘acute phase’ as it added well-known inflammation proteins like the CRP.e2 Cell Systems 7, 601–612.e1–e3, December 26, 2018
Lipid Homeostasis System
We filtered the plasma proteome for the gene ontology cellular compartment (GOCC) keywords lipid transport, chylomicron,
high density lipoprotein (HDL), low density lipoprotein (LDL), intermediate density lipoprotein (IDL) and very low density
lipoprotein (vLDL) particles. We further included non-annotated proteins well known to associate with lipid metabolism: apolipopro-
tein D (APOD), apolipoprotein(a) (LPA), Prolow-density lipoprotein receptor-related protein 1 (LRP1) and phospholipid transfer
protein (PLTP), and excluded the keyword annotated inflammation proteins SAA1, SAA2 and SAA4, which are not associated
with lipoprotein particles. Filtering for at least 10% valid values, resulted in a set of 25 proteins (Table S9). The median changes of
the proteins were calculated across all time points.
Scoring System for Insulin Sensitivity
The correlation analysis were controlled by a Benjamini-Hochberg false discovery rate (FDR) of 0.05 to take multiple hypothesis
testing into account. We ranked proteins correlating to the four insulin sensitivity parameters (‘homeostatic model assessment of
insulin resistance‘ (HOMA-IR), ‘hepatic insulin sensitivity‘, ‘peripheral insulin sensitivity‘, ‘oral glucose insulin sensitivity‘) according
to their Pearson correlation coefficient. The five proteins with the highest correlation to each of the assessments were assigned the
score 4, the next five proteins 3, the following five 2 and the rest 1 (Table S8).
Insulin Sensitivity Score
We defined an overall score for each protein adding the individual scores in each of the four insulin sensitivity assays. Next, we
normalized the protein trajectories over time, using baseline level before surgery for each individual as 100%. The score weighted
the impact of each of the proteins and the median was plotted for both RYGB studies over time.
DATA AND SOFTWARE AVAILABILITY
TheMS-based proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository and are
available via ProteomeXchange with identifier PXD009348.Cell Systems 7, 601–612.e1–e3, December 26, 2018 e3
